Investigational Drug Information for Saccharin
✉ Email this page to a colleague
▶ Start for $100
Remove trial restrictions
What is the drug development status for Saccharin?
Saccharin is an investigational drug.
There have been 11 clinical trials for Saccharin.
The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2013.
The most common disease conditions in clinical trials are Sinusitis, Parkinson Disease, and Cytomegalovirus Infections. The leading clinical trial sponsors are St. Paul's Hospital, Canada, CRDF Global, and Dalim BioTech Co., Ltd.
Summary for Saccharin
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 4,105 |
| WIPO Patent Applications | 2,914 |
| Japanese Patent Applications | 7 |
| Clinical Trial Progress | Phase 3 (2013-07-01) |
| Vendors | 90 |
Recent Clinical Trials for Saccharin
| Title | Sponsor | Phase |
|---|---|---|
| Betadine Effect on Nasal Mucosa Cilia | Boston Medical Center | Early Phase 1 |
| Povidone-Iodine Rinses as an Adjuvant Therapy Post-Operatively | St. Paul's Hospital, Canada | N/A |
| Betadine Rinses for Chronic Rhinosinusitis Prospective Cohort Study | St. Paul's Hospital, Canada | Early Phase 1 |
Clinical Trial Summary for Saccharin
Top disease conditions for Saccharin
Top clinical trial sponsors for Saccharin
US Patents for Saccharin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
